An up-to-date evaluation of dolutegravir/abacavir/lamivudine for the treatment of HIV-Reference-Cited by-同舟云学术

An up-to-date evaluation of dolutegravir/abacavir/lamivudine for the treatment of HIV

Published:2022-01-24 Issue:4 Volume:23 Page:439-446
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Christensen Brandon L¹,Tan Darrell HS¹²

Affiliation:

1. Department of Medicine, University of Toronto, Toronto, ON, Canada

2. Division of Infectious Diseases, St Michael’s Hospital, Toronto, ON, Canada

Funder

This manuscript has not been funded.

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2022.2029409

Reference70 articles.

1. Canadian Pharmacists Association. CPS: TRIUMEQ [Product Monograph] [Internet]. [cited 2021 Aug 28]. Available from: http://www.e-therapeutics.ca.

2. Department of Health and Human Services. Panel on antiretroviral guidelines for adults and adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV [Internet]. [cited 2021 Jul 19]. Available from: iv.gov/sites/default/files/inline-files/AdultandAdolescentGL.pdf.

3. European AIDS Clinical Society. ECAS Guidelines [Internet]. 2020 [cited 2021 Aug 28]. p. 1–122. Available from: https://www.eacsociety.org/media/guidelines-10.1_30032021_1.pdf.

4. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

5. Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chaotropic Chromatography Method for Simultaneous Determination of Lamivudine, Abacavir and Dolutegravir in Pharmaceutical Formulations;Chemistry Africa;2024-02-19

2. Current drugs for HIV-1: from challenges to potential in HIV/AIDS;Frontiers in Pharmacology;2023-10-26

3. A Korean Post-Marketing Study of Abacavir/Dolutegravir/Lamivudine in Patients with HIV-1;Infection & Chemotherapy;2023

4. Pharmacokinetic and pharmacodynamic features of antiretroviral products;HIV Infection and Immunosuppressive Disorders;2022-11-09

5. Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND);Current HIV/AIDS Reports;2022-07-22